VIVONA, Nicoletta
 Distribuzione geografica
Continente #
NA - Nord America 1.674
EU - Europa 822
AS - Asia 247
AF - Africa 1
Totale 2.744
Nazione #
US - Stati Uniti d'America 1.671
FI - Finlandia 231
IT - Italia 168
CN - Cina 167
UA - Ucraina 140
IE - Irlanda 68
DE - Germania 51
SG - Singapore 36
GB - Regno Unito 34
FR - Francia 29
SE - Svezia 25
TR - Turchia 19
IN - India 18
BE - Belgio 16
RO - Romania 15
RU - Federazione Russa 15
PL - Polonia 13
NL - Olanda 6
KR - Corea 5
AT - Austria 3
BG - Bulgaria 3
CH - Svizzera 2
GR - Grecia 2
MX - Messico 2
CA - Canada 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
IR - Iran 1
JP - Giappone 1
Totale 2.744
Città #
Fairfield 186
Ashburn 169
Ann Arbor 127
Chandler 117
Houston 111
Woodbridge 109
Wilmington 90
Jacksonville 79
Cambridge 77
Seattle 74
Dublin 68
Medford 46
Palermo 42
Nanjing 40
Des Moines 38
New York 34
Boardman 29
Princeton 27
Singapore 26
Tulsa 20
Izmir 19
Brussels 16
Changsha 16
Helsinki 14
Jinan 14
Beijing 13
Ningbo 13
Kraków 12
San Diego 11
Dearborn 10
Nanchang 10
Kumar 9
Altamura 8
Lawrence 8
Shenyang 8
Venice 8
Bremen 7
Hebei 6
Verona 6
Zhengzhou 6
Groningen 5
London 5
Milan 5
Pune 5
Seongnam 5
Durham 4
Düsseldorf 4
Haikou 4
Jiaxing 4
Kunming 4
Salerno 4
Taizhou 4
Tianjin 4
Catania 3
Guangzhou 3
Hangzhou 3
Ludwigshafen am Rhein 3
San Paolo di Civitate 3
Santa Clara 3
Sofia 3
Stockholm 3
Taiyuan 3
Brescia 2
Columbus 2
Falls Church 2
Forest City 2
Hefei 2
Los Angeles 2
Matamoros 2
Moscow 2
Mumbai 2
Prineville 2
Saint Petersburg 2
Sandston 2
Springfield 2
Wuhan 2
Abidjan 1
Adliswil 1
Atlanta 1
Auburn Hills 1
Baotou 1
Bergamo 1
Chicago 1
Cormeilles-en-Parisis 1
Edinburgh 1
Falkenstein 1
Frankfurt Am Main 1
Frankfurt am Main 1
Gallatin 1
Kiev 1
Kilburn 1
Kolkata 1
Lanzhou 1
Mehlingen 1
Mountain View 1
Munich 1
New Bedfont 1
Norwalk 1
Olomouc 1
Ottawa 1
Totale 1.859
Nome #
CEREBROTENDINOUS XANTHOMATOSIS: A SICILIAN FAMILY HARBOURING THE R362C MUTATION IN THE STEROL 27-HYDROXYLASE GENE 189
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 159
C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery disease patients. 152
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple‑negative breast cancer SUM 159 cells 150
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma 145
Hypertension and diabetes mellitus are associated with cardiovascular events in the elderly without cardiovascular disease. Results of a 15-year follow-up in a Mediterranean population 137
PREVALENCE OF APOB VARIANTS IN A SAMPLE OF SUBJECTS WITH HYPOCHOLESTEROLEMIA 134
A NOVEL COMPOUND HETEROZYGOUS MUTATION OF THE LIPOPROTEIN LIPASE GENE IN A NEWBORN WITH CHYLOMICRONEMIA 130
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors 130
CLINICAL AND MOLECULAR CHARACTERIZATION OF HYPERCHOLESTEROLEMIC SICILIAN FAMILIES AND DESCRIPTION OF 3 NOVEL MUTATIONS IN THE LDLR GENE 127
SEVERE MALABSORPTION AND DECREASED TRIGLYCERIDE RICH LIPOPROTEINS PRODUCTION IN A PROBAND CARRYING A MUTATION ENCODING FOR A TRUNCATED APOLIPOPROTEIN B100 VARIANT (APO B 34.8). 114
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 112
FAMILIAL LIGAND-DEFECTIVE APOLIPOPROTEIN B: IDENTIFICATION OF A FAMILY HARBOURING THE ARG3531CYS (FDB3531) OF THE APOB GENE 103
Two Italian kindreds carrying the Arg136-->Ser mutation of the Apo E gene: development of premature and severe atherosclerosis in the presence of epsilon 2 as second allele 97
ΒETA ARRESTIN-2: A NEW “ACTOR” IN THE LDL-R ENDOCYTOSIS? 95
PREVALENCE OF METABOLIC SYNDROME IN A RURAL SICILIAN POPULATION AND RELATIONS WITH CLINICAL EVENTS: THE VENTIMIGLIA HEART PROJECT. 94
INTERACTION OF THE INTRACELLULAR DOMAIN OF THE LOW DENSITY LIPOPROTEIN (LDL) RECPTOR WITH METALLOTHIONEIN2 (MT2). 84
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers. 84
VARIABLE PHENOTYPIC ESPRESSION IN A LIPID ABSORPTION DISORDER DUE TO A MOLECULAR DEFECT IN THE SARA2 GENE 80
COMPOUND HETEROZYGOUS FH AND FDB: IDENTIFICATION OF A SICILIAN FAMILY HARBOURING THE FDB3531 MUTATION AND THE Y398X MUTATION OF THE LDL RECEPTOR GENE. 79
A novel mutation in the Lipase Maturaction Factor 1 (LMF-1)gene responsible for severe hypertriglyceridemia 71
Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma: investigation of possible mechanisms 71
Possible mechanisms of Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma 60
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma 57
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil. 55
Restoration of Raf-1 Kinase Inhibitor Protein levels as a possible therapeutic approach in hepatocellular carcinoma. 54
NF-κB is a potential pharmacological target in triple negative breast cancers. 48
Totale 2.811
Categoria #
all - tutte 8.535
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.535


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020645 0 43 52 83 81 75 82 31 73 33 59 33
2020/2021306 5 45 18 37 26 7 24 17 44 24 29 30
2021/2022254 11 61 6 0 4 10 10 8 35 34 11 64
2022/2023360 47 37 4 44 44 65 26 32 41 0 16 4
2023/2024240 11 26 23 18 13 57 15 13 5 1 5 53
2024/202522 8 14 0 0 0 0 0 0 0 0 0 0
Totale 2.811